Matisse Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Matisse Capital’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-51,296	Closed	-$751K	–	194
2023 Q4	$751K	Hold	51,296	–	–	0.4%	86
2023 Q3	$739K	Sell	51,296 -30,604	-37%	-$477K	0.52%	71
2023 Q2	$1.34M	Sell	81,900 -100	-0.1%	-$1.63K	0.83%	31
2023 Q1	$1.37M	Hold	82,000	–	–	0.88%	27
2022 Q4	$1.27M	Hold	82,000	–	–	1.12%	30
2022 Q3	$1.22M	Hold	82,000	–	–	1.55%	25
2022 Q2	$1.35M	Buy	+82,000	New	+$1.41M	1.28%	19
2021 Q3	–	Sell	-107,000	Closed	-$3.09M	–	153
2021 Q2	$3.09M	Sell	107,000 -18,000	-14%	-$498K	0.98%	34
2021 Q1	$3.29M	Buy	+125,000	New	+$3.55M	0.95%	40

Other funds holding BMEZ

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SIA

Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Matisse Capital's BMEZ Position: Q1 2024 in Review

Matisse Capital sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 51,296 shares — an estimated $751K sold.

Matisse Capital first reported a position in BMEZ in Q1 2021 and held it in 9 quarters. The position peaked at $3.29M in Q1 2021. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

Matisse Capital reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
Matisse Capital sold 51,296 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $751K.
Matisse Capital first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and held it in 9 quarters.
Matisse Capital's BlackRock Health Sciences Trust II position peaked at $3.29M in Q1 2021.
99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Matisse Capital's 13F filing for Q1 2024, filed 30 Apr 2024.